Email
Print
Artesunate Tablet Market Overview:
The Artesunate Tablet Market size is
forecast to reach $260.7 Million by 2030,
growing at a CAGR of 6.2% during the forecast period 2023-2030.
The Artesunate tablet market has experienced substantial growth in recent years due to its effectiveness in treating severe malaria cases. Artesunate, a derivative of artemisinin, is a potent antimalarial drug that has shown higher efficacy in reducing mortality rates compared to other treatments. This has led to its increased adoption in malaria-endemic regions, where the disease poses a significant public health burden.
The market for Artesunate tablets is driven by the rising prevalence of malaria, especially in sub-Saharan Africa and Southeast Asia. The World Health Organization (WHO) has recommended the use of Artesunate as the first-line treatment for severe malaria, further propelling the market growth. Additionally, various initiatives by governments and non-profit organizations to combat malaria have increased the availability and accessibility of Artesunate tablets in these regions.
Market Snapshot:
Artesunate Tablet Market - Report Coverage :
The “Artesunate Tablet Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Artesunate Tablet Market.
| Attribute | Segment |
|---|---|
By Type |
|
By Applications |
|
By Geography |
|
Artesunate Tablet Market - Top Trends:
The development of new delivery methods: There is a growing demand for Artesunate Tablet in a convenient and easy-to-administer form. This is leading to the development of new delivery methods, such as oral Artesunate Tablet and Artesunate nasal spray.
The development of new formulations: There is a growing demand for Artesunate Tablet in combination with other antimalarial drugs. This is leading to the development of new formulations, such as Artesunate-mefloquine and Artesunate-sulfadoxine-pyrimethamine.
The expansion into new markets: The Artesunate Tablet market is still underpenetrated in many developing countries. This is leading to the expansion of the market into new markets, such as Africa and Asia.
The increasing awareness of the importance of malaria prevention: Governments and healthcare organizations are working to raise awareness of malaria, and they are also providing education and resources to help people prevent malaria. This is leading to an increase in the demand for Artesunate Tablet for prevention.
The Artesunate Tablet Market - Company Analysis
Fosun Pharma (Guilin): Fosun Pharma (Guilin) is a Chinese pharmaceutical company. It is the leading player in the Artesunate Tablet market. The company has a strong distribution network in China and other developing countries.
Novartis: Novartis is a Swiss pharmaceutical company. It is a major player in the global pharmaceutical market. The company has a strong research and development (R&D) pipeline for new malaria drugs.
Guilin Pharmaceutical: Guilin Pharmaceutical is a Chinese pharmaceutical company. It is a major player in the Artesunate Tablet market in China. The company has a strong manufacturing capacity.
Jiangsu Hengrui Medicine: Jiangsu Hengrui Medicine is a Chinese pharmaceutical company. It is a major player in the Artesunate Tablet market in China. The company has a strong R&D pipeline for new malaria drugs.
Key Market Players:
Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the Artesunate Tablet Market Report. The top 10 companies in this industry are listed below:
- Fosun Pharma
- Ipca Laboratories
- Sanofi Aventis
- Ajanta Pharma
- Shin Poong
- Cipla
- MCW Healthcare
- Lupin
- Glenmark
- lexicare
Scope of Report:
| Report Metric | Details |
|---|---|
Base Year Considered | 2022 |
Forecast Period | 2023 – 2030 |
CAGR | 6.2% |
Market Size in 2030 | $260.7 Million |
Segments Covered | By Type, By Applications, By Geography |
Geographies Covered |
|
Key Market Players |
|
1. Artesunate Tablet Market - Overview
1.1. Definitions and Scope
2. Artesunate Tablet Market - Executive Summary
3. Artesunate Tablet Market - Comparative Analysis
3.1. Company Benchmarking - Key Companies
3.2. Global Financial Analysis - Key Companies
3.3. Market Share Analysis - Key Companies
3.4. Patent Analysis
3.5. Pricing Analysis
4. Artesunate Tablet Market - Start-up Companies Scenario (Premium)
4.1. Key Start-up Company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Venture Capital and Funding Scenario
5. Artesunate Tablet Market – Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing Business Index
5.3. Case Studies of Successful Ventures
6. Artesunate Tablet Market - Forces
6.1. Market Drivers
6.2. Market Constraints
6.3. Market Challenges
6.4. Porter's Five Force Model
6.4.1. Bargaining Power of Suppliers
6.4.2. Bargaining Powers of Customers
6.4.3. Threat of New Entrants
6.4.4. Rivalry Among Existing Players
6.4.5. Threat of Substitutes
7. Artesunate Tablet Market – Strategic Analysis
7.1. Value Chain Analysis
7.2. Opportunities Analysis
7.3. Market Life Cycle
8. Artesunate Tablet Market – By Type (Market Size - $Million/$Billion)
8.1. Monoaromatic Artesunate
8.1.1. Market Trends by Region
8.1.2. Market Share & Forecast by Region
8.2. Compound Artesunate
8.2.1. Market Trends by Region
8.2.2. Market Share & Forecast by Region
9. Artesunate Tablet Market – By Applications (Market Size – $Million/$Billion)
9.1. Hospital
9.1.1. Market Trends by Region
9.1.2. Market Share & Forecast by Region
9.2. Clinic
9.2.1. Market Trends by Region
9.2.2. Market Share & Forecast by Region
9.3. Others
9.3.1. Market Trends by Region
9.3.2 Market Share & Forecast by Region
10. Artesunate Tablet Market – by Geography (Market Size – $Million/$Billion)
10.1. North America
10.1.1. The U.S.
10.1.2. Canada
10.2. Europe
10.2.1. UK
10.2.2. Germany
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. South America
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Chile
10.4.4. Colombia
10.4.5. Rest of South America
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
11. Artesunate Tablet Market – Entropy
12. Artesunate Tablet Market – Industry/Segment Competition Landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Product Type – Key Companies
12.1.2. Market Share by Region – Key Companies
12.1.3. Market Share by Country – Key Companies
12.2. Competition Matrix
12.3. Best Practices for Companies
13. Artesunate Tablet Market – Key Company List by Country Premium
14. Artesunate Tablet Market - Company Analysis
14.1. Fosun Pharma
14.2. Ipca Laboratories
14.3. Sanofi Aventis
14.4. Ajanta Pharma.
14.5. Shin Poong
14.6. Cipla
14.7. Acino
14.8. MCW Healthcare
14.9. Aurobindo Pharma
14.10. Torrent Pharmaceuticals
14.11. Maxter Healthcare.
14.12. Marksans Pharma
14.13. Micro Labs
14.14. Sanofi
14.15. Mylan
14.16. Emcure Pharmaceuticals
14.17. Sun Pharmaceutical Industries
14.18. Abbott
14.19. Lupin
14.20. Glenmark Pharmaceuticals
"Financials to the Private Companies would be provided on a best-effort basis."
Connect with our experts to get customized reports that best suit your requirements.Our
reports include global-level data, niche markets and competitive landscape.
The Artesunate Tablet Market is projected to grow at 6.2% CAGR during the forecast period 2023-2030.
Artesunate Tablet Market size is projected to reach $260.7 Million by 2030
The leading players in the Artesunate Tablet Market are Torrent Pharmaceuticals, Maxter Healthcare , Marksans Pharma , Micro Labs, Sanofi ,Mylan, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, Abbott, Lupin., Glenmark Pharmaceuticals